Literature DB >> 19128359

Analysis of islet inflammation in human type 1 diabetes.

A Willcox1, S J Richardson, A J Bone, A K Foulis, N G Morgan.   

Abstract

The immunopathology of type 1 diabetes (T1D) has proved difficult to study in man because of the limited availability of appropriate samples, but we now report a detailed study charting the evolution of insulitis in human T1D. Pancreas samples removed post-mortem from 29 patients (mean age 11.7 years) with recent-onset T1D were analysed by immunohistochemistry. The cell types constituting the inflammatory infiltrate within islets (insulitis) were determined in parallel with islet insulin content. CD8(+) cytotoxic T cells were the most abundant population during insulitis. Macrophages (CD68(+)) were also present during both early and later insulitis, although in fewer numbers. CD20(+) cells were present in only small numbers in early insulitis but were recruited to islets as beta cell death progressed. CD138(+) plasma cells were infrequent at all stages of insulitis. CD4(+) cells were present in the islet infiltrate in all patients but were less abundant than CD8(+) or CD68(+) cells. Forkhead box protein P3(+) regulatory T cells were detected in the islets of only a single patient. Natural killer cells were detected rarely, even in heavily inflamed islets. The results suggest a defined sequence of immune cell recruitment in human T1D. They imply that both CD8(+) cytotoxic cells and macrophages may contribute to beta cell death during early insulitis. CD20(+) cells are recruited in greatest numbers during late insulitis, suggesting an increasing role for these cells as insulitis develops. Natural killer cells and forkhead box protein P3(+) T cells do not appear to be required for beta cell death.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19128359      PMCID: PMC2675247          DOI: 10.1111/j.1365-2249.2008.03860.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  28 in total

1.  Natural killer cell signaling pathways.

Authors:  Eric Vivier; Jacques A Nunès; Frédéric Vély
Journal:  Science       Date:  2004-11-26       Impact factor: 47.728

Review 2.  Natural history of beta-cell function in type 1 diabetes.

Authors:  Nicole A Sherry; Emily B Tsai; Kevan C Herold
Journal:  Diabetes       Date:  2005-12       Impact factor: 9.461

Review 3.  Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities.

Authors:  Miriam Cnop; Nils Welsh; Jean-Christophe Jonas; Anne Jörns; Sigurd Lenzen; Decio L Eizirik
Journal:  Diabetes       Date:  2005-12       Impact factor: 9.461

Review 4.  The target tissue in autoimmunity--an influential niche.

Authors:  Natasha J Hill; Monica Hultcrantz; Nora Sarvetnick; Malin Flodström-Tullberg
Journal:  Eur J Immunol       Date:  2007-03       Impact factor: 5.532

5.  Phenotypic difference of normal plasma cells from mature myeloma cells.

Authors:  H Harada; M M Kawano; N Huang; Y Harada; K Iwato; O Tanabe; H Tanaka; A Sakai; H Asaoku; A Kuramoto
Journal:  Blood       Date:  1993-05-15       Impact factor: 22.113

6.  The natural history of lymphocyte subsets infiltrating the pancreas of NOD mice.

Authors:  A Signore; P Pozzilli; E A Gale; D Andreani; P C Beverley
Journal:  Diabetologia       Date:  1989-05       Impact factor: 10.122

7.  The histopathology of the pancreas in type 1 (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom.

Authors:  A K Foulis; C N Liddle; M A Farquharson; J A Richmond; R S Weir
Journal:  Diabetologia       Date:  1986-05       Impact factor: 10.122

Review 8.  C. L. Oakley lecture (1987). The pathogenesis of beta cell destruction in type I (insulin-dependent) diabetes mellitus.

Authors:  A K Foulis
Journal:  J Pathol       Date:  1987-07       Impact factor: 7.996

9.  B-cells promote intra-islet CD8+ cytotoxic T-cell survival to enhance type 1 diabetes.

Authors:  Gillian M Brodie; Maja Wallberg; Pere Santamaria; F Susan Wong; E Allison Green
Journal:  Diabetes       Date:  2008-01-09       Impact factor: 9.461

10.  Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production.

Authors:  Sarah E Allan; Sarah Q Crome; Natasha K Crellin; Laura Passerini; Theodore S Steiner; Rosa Bacchetta; Maria G Roncarolo; Megan K Levings
Journal:  Int Immunol       Date:  2007-02-27       Impact factor: 4.823

View more
  291 in total

1.  Evidence of increased islet cell proliferation in patients with recent-onset type 1 diabetes.

Authors:  A Willcox; S J Richardson; A J Bone; A K Foulis; N G Morgan
Journal:  Diabetologia       Date:  2010-06-09       Impact factor: 10.122

Review 2.  Histone deacetylase (HDAC) inhibition as a novel treatment for diabetes mellitus.

Authors:  Dan P Christensen; Mattias Dahllöf; Morten Lundh; Daniel N Rasmussen; Mette D Nielsen; Nils Billestrup; Lars G Grunnet; Thomas Mandrup-Poulsen
Journal:  Mol Med       Date:  2011-01-25       Impact factor: 6.354

Review 3.  Current approaches to measuring human islet-antigen specific T cell function in type 1 diabetes.

Authors:  S I Mannering; F S Wong; I Durinovic-Belló; B Brooks-Worrell; T I Tree; C M Cilio; N C Schloot; R Mallone
Journal:  Clin Exp Immunol       Date:  2010-09-15       Impact factor: 4.330

Review 4.  Virus infections: lessons from pancreas histology.

Authors:  Francesco Dotta; Letizia Galleri; Guido Sebastiani; Francesco Vendrame
Journal:  Curr Diab Rep       Date:  2010-10       Impact factor: 4.810

Review 5.  Genetics, pathogenesis and clinical interventions in type 1 diabetes.

Authors:  Jeffrey A Bluestone; Kevan Herold; George Eisenbarth
Journal:  Nature       Date:  2010-04-29       Impact factor: 49.962

6.  Beta cells under attack: toward a better understanding of type 1 diabetes immunopathology.

Authors:  Ken T Coppieters; Bart O Roep; Matthias G von Herrath
Journal:  Semin Immunopathol       Date:  2010-12-18       Impact factor: 9.623

7.  Activation of NF-κB-Inducing Kinase in Islet β Cells Causes β Cell Failure and Diabetes.

Authors:  Xinzhi Li; Yongsen Wu; Yue Song; Na Ding; Min Lu; Linna Jia; Yujun Zhao; Ming Liu; Zheng Chen
Journal:  Mol Ther       Date:  2020-07-21       Impact factor: 11.454

Review 8.  Targeting Type 1 Diabetes: Selective Approaches for New Therapies.

Authors:  Daniel F Sheehy; Sean P Quinnell; Arturo J Vegas
Journal:  Biochemistry       Date:  2019-01-17       Impact factor: 3.162

Review 9.  Pancreatic pathology in type 1 diabetes mellitus.

Authors:  Sarah J Richardson; Noel G Morgan; Alan K Foulis
Journal:  Endocr Pathol       Date:  2014-03       Impact factor: 3.943

10.  Single-Cell RNA Sequencing Reveals Expanded Clones of Islet Antigen-Reactive CD4+ T Cells in Peripheral Blood of Subjects with Type 1 Diabetes.

Authors:  Karen Cerosaletti; Fariba Barahmand-Pour-Whitman; Junbao Yang; Hannah A DeBerg; Matthew J Dufort; Sara A Murray; Elisabeth Israelsson; Cate Speake; Vivian H Gersuk; James A Eddy; Helena Reijonen; Carla J Greenbaum; William W Kwok; Erik Wambre; Martin Prlic; Raphael Gottardo; Gerald T Nepom; Peter S Linsley
Journal:  J Immunol       Date:  2017-05-31       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.